| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 22q11.21 |
PPIL2, CYP60 |
Peptidyl-prolyl isomerase-like 2 |
607588 |
|
|
R |
|
| 22q11.21 |
RIMBP3, RIMBP3A, KIAA1666 |
RIMS-binding protein 3 |
612699 |
|
|
REc, H |
16(Rimbp3) |
| 22q11.21 |
RIMBP3B |
RIMS-binding protein 3B |
612700 |
|
|
REc, H |
16(Rimbp3) |
| 22q11.21 |
RIMBP3C |
RIMS-binding protein 3C |
612701 |
|
|
REc, H |
16(Rimbp3) |
| 22q11.21 |
TRMT2A, HTF9C |
tRNA methyltransferase 2, S. cerevisiae, homolog of, A |
611151 |
|
|
REc |
|
| 22q11.21 |
TSSK2, STK22B |
Testis-specific serine/threonine kinase 2 |
610710 |
|
|
REc |
16(Tssk2) |
| 22q11.21 |
ZDHHC8, ZNF378, KIAA1292 |
Zinc finger DHHC domain-containing protein 8 |
608784 |
|
|
R, REc |
|
| 22q11.21-q12.1 |
DFNB40 |
Deafness, autosomal recessive 40 |
608264 |
Deafness, autosomal recessive 40 (2) |
|
Fd |
|
| 22q11.21-q13.31 |
ACO2 |
Aconitase, mitochondrial |
100850 |
|
distal to Ph1 break |
S, Ch |
|
| 22q11.22 |
PRAME, MAPE, OIP4 |
Preferentially expressed antigen in melanoma |
606021 |
|
|
R, REc |
|
| 22q11.22-q11.23 |
IL17RA, IL17R |
Interleukin 17 receptor A |
605461 |
|
|
R |
6(Il17r) |
| 22q12 |
AP1B1, ADTB1, BAM22, CLAPB2 |
Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta) |
600157 |
|
|
D |
|
| 22q12 |
BRV2 |
Vertigo, benign recurrent, 2 |
613106 |
Vertigo, benign recurrent, 2, 613106 (2) |
|
Fd |
|
| 22q12 |
EWSR1, EWS |
Ewing sarcoma breakpoint region-1 |
133450 |
Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3) |
t(11;22)(q24;q12); t(21;22)(q22;q12) |
Ch |
|
| 22q12 |
FSGS4 |
Focal segmental glomerulosclerosis 4 |
612551 |
Focal segmental glomerulosclerosis 4 (2); {End-stage renal disease,nondiabetic, susceptibility to} (2) |
associated with rs2032487 |
Fd |
|
| 22q12 |
GAS2L1, GAR22 |
Growth arrest-specific 2 like 1 |
602128 |
|
|
REc |
|
| 22q12 |
HMOX1 |
Heme oxygenase, decycling, 1 |
141250 |
Heme oxygenase-1 deficiency (3); {Pulmonary disease, chronicobstructive, susceptibility to}, 606963 (3) |
|
Psh, A |
|
| 22q12 |
KAZA |
Kala-azar (visceral leishmaniasis), susceptibility to |
608207 |
{Kala-azar, susceptibility to} (2) |
|
Fd |
|
| 22q12 |
MFNG |
Manic fringe |
602577 |
|
|
REa, R, A |
15(Mfng) |
| 22q12 |
MTMR3 |
Myotubularin-related protein 3 |
603558 |
|
|
R, Psh, A, REc |
|
| 22q12 |
MYP6 |
Myopia 6 |
608908 |
Myopia-6 (2) |
max lod at D22S685 |
Fd |
|